Printer Friendly
The Free Library
14,695,195 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Kobayashi Pharmaceutical Sets up New Subsidiary in Germany.


Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, Mar 20, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Kobayashi Pharmaceutical announced on March 17 that it has established Kobayashi Healthcare Germany, GmbH, in Germany as of February 20.

Capitalized Capitalized

Recorded in asset accounts and then depreciated or amortized, as is appropriate for expenditures for items with useful lives longer than one year.
 at 974,000 euros, the new subsidiary will promote Kobayashi's proprietary healthcare products and consolidate its presence in the European European

emanating from or pertaining to Europe.


European bat lyssavirus
see lyssavirus.

European beech tree
fagussylvaticus.

European blastomycosis
see cryptococcosis.
 market, starting on April 10.

Specifically, the new company will begin marketing a cooling gel sheet under the trade name of BeCOOL on May 1 in Germany.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Mar 21, 2006
Words:84
Previous Article:Dainippon Sumitomo Pharma Receives Approval for Orally Disintegrating Formulation of Amlodin, Hypertension/Angina Pectoris Treatment.
Next Article:Fuji Keizai Releases Report on Biologic Component and Material Market in Japan.



Related Articles
The rise of Eizo Kobayashi: and how investing is becoming Itochu's new business line.(UPFRONT)(Cover Story)
Kobayashi Pharmaceutical Reports Financial Results for the First Quarter Ended June 30, 2005.
Kobayashi Pharmaceutical Announces Results for the Third Quarter Ended December 31, 2005.
Medical maverick Tsuneo Kobayashi: a forerunner of cancer treatment and prevention.
Kobayashi Pharmaceutical Reports Financial Results for the Year Ended March 31, 2006.
Kobayashi Pharmaceutical, Aloe Pharmaceutical to Conclude Share Transfer Agreement.
Kobayashi Pharmaceutical Reports Financial Results for the First Quarter Ended June 30, 2006.
Kobayashi Pharmaceutical Reports Financial Results for the First Half Ended Sept. 30, 2006.
Kobayashi Pharmaceutical Announces Results for the Third Quarter Ended December 31, 2006.
Kobayashi Pharmaceutical Reports Financial Results for the Year Ended March 31, 2007.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles